FATE THERAPEUTICS INC

FATE

—

Advanced chart & tools →

FATE THERAPEUTICS INCFATE

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.15

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$6.65M

Net income

$-136.31M

Net margin

-2051.1%

Gross margin

—

Dividends & financials

FATE THERAPEUTICS INC (FATE) reported revenue of $6.65M and net income of $-136.31M, or $-1.15 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.